APA (7th ed.) Citation

Huang, X., Zheng, L., Zhou, Y., Hu, S., Ning, W., Li, S., . . . Huang, S. (2024). Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing (Adv. Healthcare Mater. 3/2024). Advanced healthcare materials, 13(3), 1. https://doi.org/10.1002/adhm.202302256

Chicago Style (17th ed.) Citation

Huang, Xiuhong, Liqin Zheng, Yueshan Zhou, Shaonan Hu, Wancheng Ning, Simin Li, Ziling Lin, and Shaohong Huang. "Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing (Adv. Healthcare Mater. 3/2024)." Advanced Healthcare Materials 13, no. 3 (2024): 1. https://doi.org/10.1002/adhm.202302256.

MLA (9th ed.) Citation

Huang, Xiuhong, et al. "Controllable Adaptive Molybdate‐Oligosaccharide Nanoparticles Regulate M2 Macrophage Mitochondrial Function and Promote Angiogenesis via PI3K/HIF‐1α/VEGF Pathway to Accelerate Diabetic Wound Healing (Adv. Healthcare Mater. 3/2024)." Advanced Healthcare Materials, vol. 13, no. 3, 2024, p. 1, https://doi.org/10.1002/adhm.202302256.